Abstract:As a member of the ATP-dependent membrane transport proteins, P-Glycoprotein (P-gp) is known to pump substrates out of cells using an ATP-dependent mechanism. The overexpression of P-gp in tumor cells reduces the intracellular drug concentrations, which decreases the efficacy of extensive antitumor drugs and leads to multidrug resistance (MDR) clinically. The combination of anticancer drugs with P-gp inhibitor has been an attractive and promising strategy to reverse MDR in cancer treatment. However, nonspecific or nonselective distribution of P-gp inhibitors to nontarget organs is one of the most fatal shortcomings in clinical application. Thus, there is an urgent need for effective and nontoxic MDR reversal agents, particularly in P-gp–mediated MDR. Traditional Chinese medicine (TCM) natural products may prove less toxic for use in P-gp inhibition to promote MDR reversal. P-gp modulatory effects have been previously demonstrated using selected TCM, including the flavonoid, alkaloid, terpenoid, coumarin, and quinonoid compounds, and some Chinese medicine extracts. Moreover, the approaches for screening active components from TCM are necessary, and these approaches face challenges. At present, the approaches to study the interaction between TCM and P-gp are divided into in vitro, in vivo, and in silico methods. This review will provide an overview and update on the role of TCM in overcoming P-gp–mediated MDR and the approaches to study the interaction between TCM and P-gp. SIGNIFICANCE STATEMENT This review summarized some traditional Chinese medicines identified to have a modulatory effect on P-gp, including flavonoids, alkaloids, terpenoids, coumarins, quinonoid compounds, and some Chinese medicine extracts, and it introduced possible mechanisms. The approaches to study the interaction between TCM and P-gp are divided into in vitro, in vivo, and in silico methods.

Advances in Reversal Agents of Multidrug Resistance to Cancer

Advances in Tumor Multidrug Resistance Reversal Agents

Recent Advances In P-Glycoprotein-Mediated Multidrug Resistance Reversal Mechanisms

Recent advances in P-gp-mediated MDR reversal mechanisms

PROGRESS IN THE MECHANISMS AND REVERSAL STRATEGIES OF MDR

Multidrug resistance inhibitors targeting P-glycoprotein

The Effects of Traditional Chinese Medicine on P-Glycoprotein–Mediated Multidrug Resistance and Approaches for Studying the Herb–P-Glycoprotein Interactions

Research Progress on Reversing Multidrug Resistance in Tumors by Using Chinese Medicine

Advances in Studies on Reversal Effect of Multidrug-Resistance by Traditional Chinese Herbal Medicine

Advances of Study on Tumor Multi-Drug-resistance and Reversal Agents

Recent Advances in the Research of P-glycoprotein Inhibitors.

Reversal of P-glycoprotein Mediated Multidrug Resistance by Traditional Chinese Medicines

Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)

Advances in Inhibitor of P-Glycoprotein

Research Advances in P-glycoprotein

Design, Synthesis and Evaluation of a Novel Series of Inhibitors Reversing P‐glycoprotein‐mediated Multidrug Resistance

New Strategies for Research and Development of P-glycoprotein Inhibitors against Tumor Multidrug Resistance

The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents

Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell

Discovery to Solve Multidrug Resistance: Design, Synthesis, and Biological Evaluation of Novel Agents

The research advance of traditional Chinese medicine to reverse the tumor multidrug resistance